352 related articles for article (PubMed ID: 37396125)
1. Beneficial effects of seaweed-derived components on metabolic syndrome via gut microbiota modulation.
Zang L; Baharlooeian M; Terasawa M; Shimada Y; Nishimura N
Front Nutr; 2023; 10():1173225. PubMed ID: 37396125
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
3. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.
Lyu M; Wang YF; Fan GW; Wang XY; Xu SY; Zhu Y
Front Microbiol; 2017; 8():2146. PubMed ID: 29167659
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.
Zhang L; Xie C; Nichols RG; Chan SH; Jiang C; Hao R; Smith PB; Cai J; Simons MN; Hatzakis E; Maranas CD; Gonzalez FJ; Patterson AD
mSystems; 2016; 1(5):. PubMed ID: 27822554
[TBL] [Abstract][Full Text] [Related]
5. Seaweed Components as Potential Modulators of the Gut Microbiota.
Shannon E; Conlon M; Hayes M
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34201794
[TBL] [Abstract][Full Text] [Related]
6. Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice.
Li X; Wang Y; Xing Y; Xing R; Liu Y; Xu Y
Hepatol Res; 2020 Jan; 50(1):5-14. PubMed ID: 31661720
[TBL] [Abstract][Full Text] [Related]
7. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
8.
Guerrero-Wyss M; Yans C; Boscán-González A; Duran P; Parra-Soto S; Angarita L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445955
[No Abstract] [Full Text] [Related]
9. Seabuckthorn (
Guo C; Han L; Li M; Yu L
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968607
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Gut Microbiota in the Effects of Early-Life Stress and Dietary Fatty Acids on Later-Life Central and Metabolic Outcomes in Mice.
Reemst K; Tims S; Yam KY; Mischke M; Knol J; Brul S; Schipper L; Korosi A
mSystems; 2022 Jun; 7(3):e0018022. PubMed ID: 35695433
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus.
Kant R; Chandra L; Verma V; Nain P; Bello D; Patel S; Ala S; Chandra R; Antony MA
World J Methodol; 2022 Jul; 12(4):246-257. PubMed ID: 36159100
[TBL] [Abstract][Full Text] [Related]
12. Seaweed Dietary Fiber Sodium Alginate Suppresses the Migration of Colonic Inflammatory Monocytes and Diet-Induced Metabolic Syndrome via the Gut Microbiota.
Ejima R; Akiyama M; Sato H; Tomioka S; Yakabe K; Kimizuka T; Seki N; Fujimura Y; Hirayama A; Fukuda S; Hase K; Kim YG
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444972
[TBL] [Abstract][Full Text] [Related]
13. The interplay between herbal medicines and gut microbiota in metabolic diseases.
Wang L; Gou X; Ding Y; Liu J; Wang Y; Wang Y; Zhang J; Du L; Peng W; Fan G
Front Pharmacol; 2023; 14():1105405. PubMed ID: 37033634
[TBL] [Abstract][Full Text] [Related]
14. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
15. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice.
Li S; You J; Wang Z; Liu Y; Wang B; Du M; Zou T
Food Res Int; 2021 May; 143():110270. PubMed ID: 33992371
[TBL] [Abstract][Full Text] [Related]
16. Maternal vitamin D deficiency aggravates the dysbiosis of gut microbiota by affecting intestinal barrier function and inflammation in obese male offspring mice.
Li P; Wang Y; Li P; Chen X; Liu Y; Zha L; Zhang Y; Qi K
Nutrition; 2023 Jan; 105():111837. PubMed ID: 36257082
[TBL] [Abstract][Full Text] [Related]
17. Ramulus mori (Sangzhi) alkaloids regulates gut microbiota disorder and its metabolism profiles in obese mice induced by a high-fat diet.
Liu D; Ye J; Yan Y; Chen Y; Wang H; Wang M; Feng Y; Li R; Xu X; Jiang Y; Lian C; Yang Y; Meng Y; Liu Y; Jiang W
Front Pharmacol; 2023; 14():1166635. PubMed ID: 37063280
[TBL] [Abstract][Full Text] [Related]
18.
Wang G; Zhu G; Chen C; Zheng Y; Ma F; Zhao J; Lee YK; Zhang H; Chen W
Benef Microbes; 2021 Jun; 12(3):267-281. PubMed ID: 34109894
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.
Duan Y; Zhong Y; Xiao H; Zheng C; Song B; Wang W; Guo Q; Li Y; Han H; Gao J; Xu K; Li T; Yin Y; Li F; Yin J; Kong X
FASEB J; 2019 Sep; 33(9):10019-10033. PubMed ID: 31167080
[TBL] [Abstract][Full Text] [Related]
20. Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review.
Birkeland E; Gharagozlian S; Valeur J; Aas AM
Lipids Health Dis; 2023 Mar; 22(1):40. PubMed ID: 36915164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
